Abstract-In this review, the critical parts and milestones for data harmonization, from the biomedical engineering perspective, are outlined. The need for data sharing between heterogeneous sources paves the way for cohort harmonization; thus, fostering data integration and interdisciplinary research. Unmet needs in chronic diseases, as well as in other diseases, can be addressed based on the integration of patient health records and the sharing of information of the clinical picture and outcome. The stratification of patients, the determination of 
I. INTRODUCTION

C
OHORT STUDIES offer invaluable sources of biological, health, environmental, behavioral, and psychosocial data and have given rise to multiscale predictive data analysis. The information gathered from large population-based cohorts allow leveraging of public health and clinical medicine. Moreover, access to studies that incorporate different types of research data would permit the investigation of direct and/or indirect disease aetiological determinants. To this end, the analysis of synthesized datasets across population-based studies is set to become increasingly important [1] . The heterogeneity of existing cohorts, stemming from variability in experimental design, measurement, and standardization methods, supports the realization of aggregated schemes toward the development of precision medicine solutions. Additionally, making the data findable, accessible, interoperable, and reusable enables data sharing. Data sharing includes 1) the procedures for data access, 2) the mechanisms for dissemination, 3) the tools and software for data reuse, 4) the definition whether data access should be widely open or restricted, 5) the prohibition period that may exist [2] .
The need for data harmonization enables the cross-national and international comparative research, while it enables the investigation of similarities and differences across longitudinal datasets when compatible data are available [3] .
Data harmonization refers to the creation of a standardized, comprehensive database/schema, combining data generated from different sources (e.g., epidemiological studies, clinical studies), and facilitating data integration and interdisciplinary research. The increase of sample size and the improvement of generalizability and validity of research results constitute the most significant benefits of the harmonization process [4] , [5] . Global initiatives have incorporated data harmonization in their design in order to investigate and/or identify risk factors of complex chronic diseases. Examples of such initiatives aim to bring out the value of health data through large-scale analytics and ensure the development of harmonized measures and standardized computer infrastructures [6] . The ability to effectively harmonize data from different studies and patient cohorts facilitates the rapid extraction of new scientific knowledge on disease onset, disease progression, and classification of different disease phenotypes. This type of approach can certainly address the unmet needs of chronic diseases including 1) validation or identification of novel biomarkers, 2) patient stratification for different treatments, 3) selection of new targets for therapy. Furthermore, this approach will enable the decisive evaluation of disease features, comorbidities, remissions, exacerbations, etc. Additionally, it will allow the scientific societies to collaborate efficiently with patient associations as well as the regulatory mechanisms in each country.
Research guidelines for rigorous data harmonization encompass 1) the definition of the research questions, objectives, and protocol; 2) the collection of appropriate information and selection of studies; 3) the definition of variables and evaluation of harmonization potential; 4) the processing of data; 5) the estimation of the quality of the harmonized dataset [7] . Evaluation of harmonization potential refers to the clinical evaluation of whether a clinical dataset under examination is capable of being harmonized. This procedure is related to two factors, namely: first, the data sharing regulations, i.e., whether or not the sharing of the clinical data is possible to enable harmonization; and second, the quality of the dataset, i.e., if the dataset meets the minimum requirements. In fact, the quality of the dataset determines the harmonization potential in a technical manner. For example, a well-qualified dataset will lead to a larger matching probability with the reference model than a less qualified dataset. A reference model consists of the minimum number of features (e.g., clinical parameters) which enable the explicit description of a disease's domain knowledge. Data integration strategies, taking advantage of contemporary Semantic Web technologies, aim at maximizing the exploitation potential of synthesized datasets across multidisciplinary studies. Indicative techniques rely on automated or supervised creation of data schemas using vocabularies and ontology mapping [8] , [9] .
This review analyzes previous research and presents new trends on longitudinal cohort harmonization, while it discusses the significant challenges occurring when managing and harmonizing large amounts of data from different sources. Ethical, legal, and related restrictions associated with sharing and pooling individual-level information are also discussed. Current techniques, ranging from data standardization models to advanced ontology-based and semantic interlinking technologies, enabling the creation of links among diverse datasets, are presented. Several case studies, related to the data pooling and harmonization of disparate cohorts, are presented and discussed. These approaches reveal the benefits of integrating diverse sets of multilevel biomedical data so as to compare and enhance the statistical power of validated models, as well as improve the management of the healthcare system. Furthermore, future directions in the field are discussed. Considering that new technologies have not been holistically validated and evaluated, this review contributes positively to the adoption of new practices in data harmonization and scalable cohort analytics for knowledge discovery.
Data harmonization is more prominent in chronic diseases, in order to address unmet needs, such as: 1) patient stratification and 2) biomarker identification and/or validation. This comprises a fundamental basis of our work, while additional references to other diseases with their related studies are considered (e.g., obesity and ageing). The following sections of this review constitute a comprehensive description of 1) data harmonization from the clinical perspective and its importance on addressing the unmet needs in chronic diseases, 2) the technical perspectives when data integration should be conducted, 3) the ethical and legal issues, 4) the existing case studies related to data harmonization, 5) the discussion for supporting coanalysis of harmonized datasets from a biomedical engineering perspective.
II. HARMONIZATION IN CHRONIC DISEASES
The application of existing or newly identified therapeutic targets in everyday clinical practice is hampered by the incomplete understanding of chronic disease pathogenesis, the lack of validation of potential indices in large patient cohorts, and the disease heterogeneity. In addition, the complex pathogenetic mechanisms involving, to a different extent, various systems (immune, endocrine, neuroendocrine, etc.) further hinder the successful application of a sole omics' technology (as attested by genome-wide association studies) for the discovery of novel pathogenetic/therapeutic targets. These observations highlight the need for the classification of patients with chronic disease in subgroups with homogeneous clinical profiles, disease duration, and similar outcome, as well as for transdisciplinary research involving clinical and basic researchers for the delineation of the underlying pathogenetic pathways and the identification/validation of novel therapeutic targets. Besides the clinical and medical research observations that support the need for integrating different cohorts in chronic diseases, there are additional considerations and rationales that make the integration of cohorts an urgent need. In terms of theoretical rationale, the integration of different cohorts can solve the issue of generalizability. The importance of generalization ability of study outcomes has been discussed in the literature. For cohort studies, limited representativeness may mean that results cannot be assumed to be true for unsurveyed or underrepresented subsets of the population of interest. The second theoretical rationale has to do with the interest in known or potential sources of heterogeneity, which are mainly syntactic, semantic, and/or conceptual, and may also exist due to the different geographical locations of the patients. In addition, other sources of such heterogeneity refer to factors that can influence differences within or between study outcomes (e.g., genetics). Cross-national studies allowing assessment of the influence of social policy and environment on health outcomes are perhaps the best known examples of such investigations. The third theoretical consideration has to do with the specific unmet needs of chronic disease. The inferences, causalities, associations, or new knowledge that researchers wish to draw from combined data determine whether pooling individual data is a worthwhile undertaking. Finally, a fourth theoretical consideration deals with the directions of future research; these can be identified based on gaps in current knowledge. However, since most of the studies and literature in chronic diseases refer to single regional or national cohort analysis, pooled data analyses of integrative cohorts may assist in addressing new research questions. The second type of rationale has to do with the statistics and the benefits of increased sample size. Low prevalence outcomes are infrequently reported in local cohorts. Hence, larger samples are required to obtain adequate data for the analysis of predictors and consequences of these outcomes. The last category of rationale has to do with practical considerations. When using existing data, results may be obtained in a timely manner compared to initiating a new study. Consequently, answers to research questions can be accelerated, particularly where outcomes are of importance to the public, or when the unmet needs have already been identified. Such results are relatively cost efficient, and can often be obtained without unnecessary duplication of tasks or additional burden on the target population. In the case of survey-based cohort studies, reducing the necessity of identifying additional participants, and sending, receiving, and processing survey data for analysis, may mean that the greatest costs associated with survey methods are eliminated.
Facilitating the integration of patient records and the sharing of information of the clinical picture and outcome will permit the stratification of patients, the determination of various clinical and outcome features, such as comorbidities and mortality ratios, which up to now have been studied in various small patient groups, the development of diagnostic, follow-up, and therapeutic algorithms, as well as biomarkers for the different phenotypes of the disease. Thus, unmet needs in chronic diseases can be addressed, namely, 1) the validation or identification of clinical, laboratory, and molecular biomarkers for early disease diagnosis, followup, and response to treatment; 2) the stratification of patients to distinct subgroups according to clinical picture and outcome for different treatments; 3) the selection of new targets for therapy. Table I summarizes the unmet needs that characterize chronic diseases and how they can be addressed through data harmonization and data sharing, along with related works which have been published in the scientific and clinical research literature. Additionally, Fig. 1 illustrates a conceptual stepwise categoriza- tion in chronic diseases along with the unmet needs that can be addressed through harmonization. Toward this categorization, particular steps are considered with reference to 1) the clinical stratification, 2) the histologic stratification, 3) the systems biology approaches for patient molecular stratification, 4) the homogeneous patient groups for targeted therapy. Hence, unmet needs in chronic as well as other diseases can be further considered and studied thoroughly regarding the utilization of the harmonization perspective [10] . In order to achieve harmonization and address the unmet needs, specific technical steps which contribute to the definition of the research objectives and the analysis of harmonized datasets should be followed. Moreover, the analysis of the output results can be further achieved through appropriate information technology (IT) infrastructures and algorithms that allow the federated analysis of pooled datasets.
III. TECHNICAL PERSPECTIVE
This section introduces the research tools which enable researchers to address the unmet needs in chronic diseases through their utilization based on the harmonization initiative. Achieving data harmonization as a rigorous scientific process is a demanding task. Data harmonization, from the technical perspective, is an iterative process consisting of related and interdependent steps. To better understand the key steps toward data harmonization approach, effective and rigorous technical methods and tools have been developed [1] .
Recently, the iterative key steps toward harmonization of research data have been delineated by Maelstrom Research and its partners [7] . These principles aim to promote a systematic procedure for data harmonization and a methodological guidance for researchers which integrate heterogeneous data from different cohorts for the synthesis of harmonized datasets [10] . An overview of the key steps toward data harmonization process is depicted in Fig. 2 . The four closely related steps that should be considered during the harmonization workflow include 1) definition of the objectives and research questions, 2) data discovery and study selection, 3) definition of the target variables and data processing, 4) coanalysis of the harmonized dataset(s). A comprehensive description of each step is given below along with their basic aims and the key services and software developed to support the harmonization and coanalysis of the results. Tasks 1) and 4) compose the main tasks to be addressed at the initial and final stages of data harmonization. The remaining Steps 2) and 3) refer to the underlying principles that generate the synthesized dataset(s) required for further statistical analysis.
The indicative key steps have been addressed by many case studies in the literature highlighting the main contributions of data harmonization in large patient datasets and health records. Moreover, legal and ethical issues should be considered and addressed during the process of data integration for each harmonized cohort.
A. Definition of the Objectives and Research Questions
A research protocol that reflects the potential and the limitations should be developed prior to the data harmonization process. This protocol defines the research questions to be addressed and the objectives that ensure the viability and reproducibility of the process. Issues to be considered in this initial step are study specific [11] as well as common tasks and are related to 1) data access procedures and usage, 2) data infrastructure to be implemented, 3) study designs and type of information required, 4) type of data and how they are collected, 5) quality of the data. Moreover, questions related to the proprietary rights of the synthesized datasets and the specific responsibilities of the stakeholders involved in the harmonization process must be addressed due to the number of the participating individual studies. Based on the research protocol, information regarding the scientific, methodological, and administrative tasks is gathered. In addition, ethical and legal concerns are defined toward the harmonization procedure.
Recently, established legal frameworks introduced several requirements on data management and sharing to relevant stakeholders [12] . Those requirements are suggested to be addressed through the development of an adequate data management plan which includes information on 1) the research data handling, 2) the type of data to be collected, processed and/or generated, 3) the methodology and standards to be applied, 4) the data sharing, curation, and preservation [13] .
B. Data Discovery and Study Selection
The second step prior to the harmonization workflow is related to: 1) the accumulation of information and 2) the selection of the participating studies. Gathering information for the highlevel data concepts and the study designs ensure the appropriate knowledge of each individual study. Procedures for better understanding the legal and ethical issues and the comprehensive characterization of the studies through research protocols, questionnaires, and operating procedures are essential to support study selection and data harmonization.
The selection of the participating studies is based on rigorous criteria to ensure consistency and compatibility among them. Hence, eligible studies involved in a harmonization process must be comparable and share common characteristics to address the research questions and objectives. Several tools and services have been developed for data description, presentation, and discovery by the Biobank Standardization and Harmonization for Research Excellence in the European Union (EU; BioShare) project [1] and the Observational Health Data Sciences and Informatics (OHDSI) initiative [6] .
Café Variome [14] provides a data discovery platform in order to make content available to data scientists and researchers. Users search for data records of desired studies and the list of matching records is exported. Three categories are available for accessing the data, i.e., openAccess, linkedAccess, and restrictedAccess. The tool has been built in PHP using the CodeIgniter Web application framework and the Bootstrap front-end framework. The system enables controlled data sharing based on data discovery. Generally, Café Variome is used for genotype-phenotype data searching and sharing and allows for the discovery of patient health records. In addition, it has the ability to modify any data field or attribute of interest and reports all the matched records to the user.
Due to the huge amount of data generated from omics technologies, it is difficult to synthesize and explore such information. OmicsConnect [1] is a software tool that enables viewing and sharing of omics data. It has been designed for presentation, access, and mining of complex genomics data.
The Mica software application [1] is a Java-based clientserver application developed to create web portals for specific studies. It is used to 1) create a website for an individual study or a consortium, 2) create a study catalog or registry according to the data collected, 3) enable efficient data access management. It has been designed for database owners and researchers so as to give access to data and spread information about studies as well as search and query data, respectively. Nowadays, Mica is used by several cohort studies and allows to report key characteristics of the participating biobanks and cohorts.
The Molecular Genetics Information System/Observation Entity Model Extensible (MOLGENIS/Observ-EMX) [15] - [17] has also been designed for data search and analysis. It is a portal for data management and permits the integration, discovery, and analysis of scientific data. Moreover, it enables data annotation through public databases, flexible data exploration, and data access.
During the OHDSI program, the WhiteRabbit tool [6] has been developed aiming to enable researchers scan datasets of interest and extract summary information on the contents of the data for further integration and standardization. Subsequently, the dataset of interest can be matched to the desired common data model.
C. Definition of the Target Variables and Data Processing
Data integration and pooling across biobanks and cohorts is the main process when conducting data harmonization. Concerning this, the identification of the target variables and the evaluation of the harmonization potential is vital. In order to define the list of core variables to be generated, researchers should evaluate first if the individual datasets could be used so as to generate the target variables. Moreover, the potential for each specific study to select the variables for harmonization should be defined, based on the fact that not all studies can create all the variables. To this end, quality is ensured and the harmonization procedure can be achieved. The evaluation of the harmonization potential is assessed by comparing the desired data elements within biobanks and finding the matching elements. Furthermore, finding the mappings of data items across individual studies depends on the research questions and objectives defined prior to data harmonization process.
Toward this, Semantic Web technologies [18] - [20] provide a rigorous solution to automatically integrate disparate information sources and databases. These technologies and principles have been created by the partners of the World Wide Web Consortium (W3C) [21] , so as to enable the expression of both data and rules for reasoning about the data. Semantic Web technologies are entitled by the sort of data found in databases and allow reasoning over data through rules from any existing knowledgerepresentation system to be exported into the Web. Moreover, the vision of linked data on the Web, enabled developers to create data stores, build vocabularies, and write rules for handling data. Modeling heterogeneous information between web resources on the Semantic Web is empowered by technologies such as 1) the Resource Description Framework (RDF) [22] , [23] , 2) the SPARQL Query Language for RDF [24] , 3) the Web Ontology Language [25] , [26] , 4) the Simple Knowledge Organization System [27] . When conducting data harmonization, researchers should be concerned with the fact that different cohorts may use different identifiers for the same data element of same meaning. When comparing or combining information across databases, features that represent common concepts should be discovered. Based on that knowledge, ontologies or vocabularies can be applied for data integration [28] . Ontologies define the terms and the relationships among them used to describe a specific area of concern. They can help in data integration, when heterogeneity exists on the identifiers used within different cohorts or when new relationships among data elements can be discovered. Besides that, ontologies can be used to organize knowledge regarding the power of linked data on the Web. Different techniques have been proposed so as to specify and determine a common format for the different forms of ontologies (vocabularies) [22] , [25] , [27] , [29] . In addition, Open Biological and Biomedical Ontology (OBO) Foundry [30] , which is a collective of ontology developers, incorporate a family of interoperable ontologies that have been developed and are both logically well-formed and scientifically accurate. A reference model is usually codesigned with the assistance of the clinicians so as to meet the minimum requirements of a disease's domain knowledge. This model describes all the terminologies, the types of variables, and the related measurement units that a clinical dataset should fulfill. Each heterogeneous clinical dataset is then transformed into this reference model. One possible approach to make this transformation possible is to recruit semantic interlinking mechanisms by 1) constructing an ontology from the heterogeneous clinical dataset and 2) mapping this ontology to the main ontology, i.e., the one created by the reference model. For example, if the reference model defines the measurement unit of the variable named "blood pressure" as "normal" or "abnormal," and a candidate clinical dataset follows another coding system, e.g., "normal," "high," "very high," then the latter shall be appropriately transformed to fulfill the "normal," "abnormal" coding system (e.g., assign the "high," "very high" values to "abnormal"). This example formulates one of the key issues that harmonization wishes to achieve.
During the last decade, the huge amount of information available from different databases and the variations on the concepts and relationships of their data elements, led to the semantic heterogeneity problem, which is a different terminology used for describing equivalent concepts. Consequently, in order to overcome the problem related to the management of heterogeneous information sources, ontology matching techniques have been proposed [31] , [32] . Matching ontologies enable the identification of correspondences among semantically related terms of ontologies, based on their meaning. The applications of ontology matching are characterized of models with heterogeneity, such as the database schemas of specific individual studies. Several matching systems have been proposed in the literature. These matching systems are based on the kind of data that are utilized, i.e., 1) strings (terminological or lexical systems), 2) structure (structural systems), 3) instances (extensional systems), 4) models (semantics methods) [8] , [31] , [33] - [47] . Fig. 3 illustrates the semantic matching process along with an indicative example [31] . Different ontologies can be matched according to the related correspondences of their entities. More specifically, Fig. 3(a) demonstrates the general strategy for semantic matching, whereas Fig. 3(b) depicts an indicative example of semantic interlinking among the correspondences of two different ontologies. Ontology 1 corresponds to a treatment schema and Ontology 2 to disease diagnosis.
A number of integrated tools and methods have been developed during the BioSHaRE project [1] , [48] related to research data harmonization. Most of these tools have been deployed for data pooling and for identifying the mappings of variables across different datasets. More specifically, the BiobankConnect software [9] enables the connection of data across biobanks for pooled analysis by employing ontology and lexical matching. Data mapping is achieved and subsequently harmonization of biobanks data dictionaries can be fostered. In a similar manner, the DataSchema and Harmonization Platform for Epidemiological Research (DataSHaPER) approach [4] , [5] provides an integrated method for the harmonization of large population studies. The development of the Generic DataSchema tool enables the generation of a list of core variables among participating studies through a template that defines common format measures. Opal software [1] allows users to perform data harmonization and data integration across studies. Furthermore, the processing and implementation of algorithms through Opal support the transformation of study-specific variables into common formats. Another framework, the System for Ontology-based Recoding and Technical Annotation (SORTA) [49] , has been developed for the annotation of biomedical and phenotype data. SORTA Fig. 3 . Illustration of the semantic matching procedure. (a) The matching process can be seen as a function which, from a pair of ontologies to match, i.e., Ontolog y1 and Ontolog y2, an input alignment with correspondences between the ontologies, a set of parameters and a set of resources, returns a new set of correspondences between these ontologies, resulting in a new ontology [31] . (b) Alignment between the Treatment and Disease Diagnosis ontologies. Correspondences are shown as red arrows that connect an entity from one ontology with an entity from another ontology. The entities are annotated with the relation that is expressed by the correspondence.
overcomes the problem of semantic heterogeneity and matches original data values to a target scheme. Specifically, SORTA solves the obstacles of heterogeneity of data contents by mapping text descriptions and/or coded data values with standard codes such as ontologies or local terminologies. Suppose that we need to retrieve the most relevant matches of a list of terms such as: 1) protruding eyeball, 2) hearing impairment, and 3) hyperextensibility at elbow joint, against the Human Phenotype Ontology. SORTA, will retrieve the most relevant concepts for data values from the established knowledge base and users can pick the correct matches from the list of concepts. In our example, SORTA can select the ontology term for protruding eyeball, i.e., proptosis, and a number of synonyms will be retrieved, i.e., prominent eyes and prominent globes.
Furthermore, the MOLGENIS/connect system [16] also addresses the challenge of linking and harmonizing disparate archives of heterogeneous phenotype data. MOLGE-NIS/Connect is an additional system to BiobankConnect which matches data elements from biobanks to target variables/schemes. In general, it is a semiautomatic system that effectively defines the transformation algorithms in order to produce integrated datasets. Specifically, the data elements and the DataSchema can be viewed by the users. A semantic similarity facility is provided to find the best matching elements according to the DataSchema. Toward this approach, other tools have been also developed, such as the RD-Connect software [50] . However, the main objective of this tool is to simply aggregate data from different sources, creating a platform of linked data which are further processed. The Sample Availability (SAIL) method [51] has been created for harmonizing and integrating biomedical and clinical data across cohorts in order to further support research. Within the OHDSI interdisciplinary collaborative [6] , resources to convert a wide variety of health data into a common data model are provided. Specifically, ATHENA [52] and Usagi [53] are tools that have been built to help with the standardization of vocabularies and the vocabulary mapping, respectively, before the creation of the common data schema. SNOMED CT [54] is the most comprehensive, multilingual clinical healthcare terminology in the world. It is a resource with comprehensive, scientifically validated clinical content, and enables the consistent representation of clinical content in electronic health records. Toward the development of the ATHENA software application and its application design, a stream of concepts (i.e., attributes of existing concepts, new concepts, missing concepts, etc.) is extracted from SNOMED international authoritative source in combination with SNOMED UK. widely from research groups toward data harmonization process and data integration. Research data integration strategies that foster the sharing of information from individual studies are supported from contemporary Semantic Web technologies [22] .
D. Coanalysis of the Harmonized Dataset(s)
Once the harmonized dataset has been created, according to the methodologies and principles mentioned above, further coanalysis of the results should be performed. Therefore, the quality of the final dataset generated should be estimated and assessed. Specific quality procedures could verify loss of precision and/or key characteristics which are source of bias. Furthermore, defining and implementing a sustainable infrastructure in order to maintain the results of the harmonization process is of great importance. To this end, the last step of the process when all the variables are harmonized, is to coanalyze the dataset(s) aiming to address the questions posed by researchers. There are three types of analysis to coanalyze data, namely, 1) pooled analysis, 2) summary data meta-analysis, and 3) federated analysis [7] . In the pooled analysis, data are integrated in a central location and then analyzed. Since data are centrally stored, flexibility is achieved for further statistical analysis. Nonetheless, important legal and ethical issues rise when pooling data. In the second type, study-specific data analysis is done locally and is followed by a meta-analysis that combines the study-level estimates. Few ethics and data access requirements exist, while this type of analysis is not so flexible because it is limited to the summary statistics produced by each study. On the contrary, in the federated analysis, the selected studies maintain the complete control of their datasets and the analysis is performed centrally. However, each individual dataset remains on local servers. The Data aggregation through anonymous summary-statistics from harmonized individual-level databases (DataSHIELD) method provides powerful tools and functions that permit the federated statistical analyses of pooled datasets of several collaborating studies [55] , [56] . It enables a fully efficient integrated analysis of biomedical data even if ethical and/or legal considerations do not allow the spread of individual-level data to third parties. More specifically, Fig. 4 illustrates the basic IT infrastructure underlying the DataSHIELD method, where individual datasets remain on data computers locally, whereas, an additional computer is identified as the analysis computer, centrally. Additionally, the Estimating Sample-size and Power in R by Exploring Simulated Study Outcomes (ESPRESSO) tool [57] , [58] enables researchers to define the statistical power concerning a given set or target sample size. It also allows one to calculate the sample size required to achieve specific statistical results. With ESPRESSO and its functions, the assessment of errors in power calculation under various biomedical scenarios can also be achieved. Fig. 5 presents an overview of the ESPESSO algorithm [57] .
Cohort definition and syntax compiler tool [Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES) and Criteria Assessment Logic for Your Population Study in Observational data (CALYPSO)] are large-scale analytic tools that support the cohort definition, the patient record profiling, and the study feasibility assessment, respectively, once patient-level datasets have been integrated into a common data format [6] . The characterization of the extracted dataset through a comprehensive description and the validation of the data quality can be achieved. Moreover, the evaluation of the impact of the study is enabled through the CA-LYPSO tool. In addition, open-source large-scale analytic tools, through R [59] , and scalable to big data have been developed in [6] for an end-to-end analysis from common data formats through evidence.
IV. LEGAL AND ETHICAL ISSUES
A. Data Sharing and Data Protection
One of the major issues to consider when sharing and harmonizing data from different cohorts is the protection of ethical and legal aspects of the shared and harmonized data. Toward this, several different aspects and methodologies/policies have been identified by either the clinical centers participating in data sharing or expert legal offices that have been assigned the role of solving the legal constraints to share data between different countries with different data protection laws and regulations. The innate sensitivity of biomedical information has led to a set of principles and rules for safeguarding protection and privacy of personal data in all stages of data manipulation starting from data collection protocols to data analysis infrastructures.
The evolution of big data and their multipurpose utilization toward new knowledge mining, which is enabled by innovative developments in IT, pose new challenges that need to be addressed in the context of informed consent, privacy of data, ownership, and epistemology in assessing big data ethics and objectivity of big data [60] . For instance, a comprehensive essay centering on issues regarding consent obtaining in biobank studies recognized the need for a defensible, sustainable, and conceptually coherent consent policy [61] . Adapting freely given, specific, and informed consent along with anonymization mechanisms such that 1) facilitating the process of dynamic reconsent through the use of IT providing a transparency level between individuals and their data and 2) balancing the need for irreversible anonymization and data linkage and continuing data update, are key issues in the protection of individuals with regard to the processing of personal data [60] - [65] .
B. Harmonizing Data Protection Laws
1) EU General Data Protection Regulation (GDPR):
The intensified interest on big data sharing, aggregation, linkage, and analysis yielded to the forthcoming replacement of the EU Data Protection Directive (DPD) 95/46/EC by the GDPR. At the heart of the EU DPD and GDPR lie the principles of fairness and lawfulness assuring the openness and legality of the use of personal sensitive data. The GDPR (http://www.eugdpr.org/eugdpr.org.html) mainly overhauls the EU Directive 95/46/EC with respect to rights of the data subject by introducing or strengthening the rights to: 1) access to data, 2) rectification and erasure ("right to be forgotten"), 3) data portability, and 4) notification for a personal data breach. In addition, the concept of privacy by design calls for the effective implementation of appropriate technical and organizational measures (e.g., pseudoanonymization) from the design phase of a system in order to ensure nonattribution to an identified or identifiable natural person and meet the requirements of GDPR. The conditions for consent have been also strengthened requesting clarity of the information provided to the individuals.
2) Framework for Responsible Sharing of Genomic and
Health-Related Data: The EU BioSHARE Project has developed, under the aegis of the Global Alliance for Genomics and Health, the Framework for Responsible Sharing of Genomic and Health-Related Data [66] - [69] . This framework has established a set of foundational principles for responsible sharing of genomic and health-related data 1) respect individuals, families, and communities; 2) advance research and scientific knowledge; 3) promote health, wellbeing, and the fair distribution of benefits; 4) foster trust, integrity, and reciprocity. In addition, it has set out ten core elements complementing the interpretation of the aforementioned principles: 1) transparency; 2) accountability; 3) engagement; 4) data quality and security; 5) privacy, data protection, and confidentiality; 6) risk-benefit analysis; 7) recognition and attribution; 8) sustainability; 9) education and training; and 10) accessibility and dissemination.
C. Data Protection Technological Solutions
1) DataSHIELD. An Ethically Robust Solution to Multiple-
Site Individual-Level Data Analysis: An exemplar technological solution to prevent reidentification of an individual has been proposed within the DataSHIELD initiative by "taking the analysis to the data, not the data to the analysis," which confines the control researchers retain over the data. In particular, DataSHIELD "enables the coanalysis of individual-level data from multiple studies or sources without physically transferring or sharing the data and without providing any direct access to individual-level data" [70] , [71] . The latter feature contributes significantly to properly addressing several ethicsrelated concerns pertaining to the privacy and confidentiality of the data, the protection of the research participant's rights, and the postdata-sharing concerns. In addition to standard technical and administrative data protection mechanisms, DataSHIELD includes 1) a systematic three-level validation process of each DataSHIELD command for risks of disclosure, 2) output restrictions to impede disclosure of possibly identifiable objects, 3) automatic generation of new subject's identifiers by Opal (original subject's identifiers are stored securely in a distinct database in Opal), 4) protection mechanisms from potential external network attacks, 5) encrypted and secured Internet communications. It should be noted that ethico-legal and data access approvals as well anonymization of the data constitute necessary preliminary setup steps required for the DataSHIELD-based analysis.
V. CASE STUDIES
The presented case studies are mainly comprised of novel worldwide initiatives that involve medical data harmonization, with emphasis in chronic diseases. The ensuing case studies are mainly based on the data harmonization strategy that has been presented in Fig. 2 , with differences in the implementation of the harmonization approach according to the context of each study.
In an aging study [72] , Bath et al. extracted 26 harmonized variables (across 1768 records) for different attributes (such as socio-demographic, physical and social activity, mental health, etc.) based on the longitudinal data obtained from older people across two cohorts (one Dutch and one British). According to the harmonization procedure, several study-related values were merged across studies, under certain assumptions, and then new variables were created for representing identical variables, based on appropriately predefined research questions. Furthermore, standardization procedures were adopted to facilitate score comparisons across the two cohorts by minimizing age and period effects across the studies. Finally, differences in sampling, study design, measurement instruments, response rates, and selective attrition were presented as the fundamental methodological challenges for cross-national studies.
In [73] , Bennett et al. provide guidelines for phenotype harmonization in order to deal with the phenotype heterogeneity across several genome-wide association study (GWAS) consortia using the Gene Environment Association Studies multisite GWAS consortium. Their main objective was to create a centralized database for all phenotype and genotype data, therefore enabling cross-study analyses. A context-specific harmonization procedure was adopted. More specifically, a common set of covariates was first identified (a process referred to as uniform covariate selection) across all cohorts with proper adjustments being made wherever possible. Otherwise, stratifications or even exclusions were applied. Finally, the study described methodological challenges on phenotype harmonization that may appear useful for similar studies using GWAS cohorts. Guidelines for a stepwise data harmonization procedure, in cancer epidemiology, are also described in [10] where the harmonization procedure took place in the Fred Hutchinson Cancer Research Center (Fred Hutch) using data from four large consortia.
The potential of harmonizing physical capabilities variables as well as testing for the effect of age and gender interactions across eight U.K. cohorts (∼40 000 individuals, under the HALCyon (Healthy Ageing across the Life Course) research program was assessed in [74] , indicating that data harmonization is possible indeed, with (statistically) significant gender differences in two physical measures. The data harmonization procedure is followed by several examples concerning the creation of harmonized variables for a variety of attributes, such as grip strength, walking speed, standing balance, and other related measures. Adjustments and standardizations were further applied on several physical measures to ensure measure-related compatibility across the cohorts. The effects of age and gender were also investigated per physical capability measure. Moreover, new variables were constructed, under certain assumptions, to facilitate harmonization.
In [75] , Schaap et al. constructed a harmonized database including data from 10 107 persons using longitudinal data from five European cohorts on osteoarthritis (OA), based on existing guidelines from the Comparison of Longitudinal European Studies on Aging (CLESA) project [76] . The proposed harmonization procedure was developed under a sequentially based algorithm by taking into consideration 1) the availability of a variable across at least three out of five cohorts, 2) the measuring concept, 3) the overlapping of the response categories of that variable. This scheme was repeated for all variables of interest. An extra weighting procedure was further applied after merging the datasets in order to adjust for age, sex, and sample size variations across the datasets.
Apart from the context-specific harmonization methods, several attempts have been made toward establishing a generalized harmonization platform. An example of such a platform is presented in [5] along with an illustrative example of the pairing rules developed for one variable, under the task of (successfully) assessing the potential of harmonizing 50 large population-based studies on diabetes. The platform, which is known in the related literature as the DataSHaPER, is a dynamically evolving entity comprised by two major platforms: the DataSchema Platform and the Harmonization Platform.
The DataSHaPER method has been also applied in [4] for assessing the potential of harmonization across 53 of the world's largest longitudinal population-based epidemiological studies (6.9 million participants in total) containing a large variety of variables related to different pathologies, such as cancer, stroke, diabetes, etc. About 36% compatibility for creating a completely harmonized dataset was found. This percentage was higher (i.e., 62%) if only the "essential" variables participated during the harmonization procedure. According to the harmonization procedure, all variables were first categorized based on their importance for broad-based epidemiological studies as "essential," "important," and "useful." The DataSchema variables were initially identified (148 variables in total; 38 essential, 45 important, and 65 useful) and then the potential of generating each DataSchema variable was further evaluated for each study individually, through the development of context-specific sets of pairing rules per variable. These pairing rules were also examined in order to control for possible pairing errors. In a similar study [1] , [48] , the authors developed a complete stepwise data harmonization approach based on the DataSHaPER and on tools developed by OBiBa (i.e., Mica software for developing web portals for studies and Opal software for data harmonization and integration [1] , [48] ) for the Healthy Obese Project (HOP) with the purpose of identifying metabolically healthy obese individuals across eight large cohorts (229534 subjects in total). About 73% compatibility for creating a harmonized HOP database was discovered. The potential of generating the DataSchema variables from each individual study was explored by recruiting and testing the appropriateness of any study-specific data related to the DataSchema variables. The latter were selected from each dataset individually, according to appropriately defined research questions, leading to a set of 96 target variables in total. This set was finally employed as a template for data harmonization.
An additional very important initiative in the domain is the European Project entitled Electronic Health Records for Clinical Research (EHR4CR) funded through the Innovative Medicine Initiative of the European Commission [77] . The EHR4CR platform is an open IT platform that unlocks the information stored in Electronic Health Records for improving clinical research while fully respecting patient privacy and ensuring a high level of security. Data harmonization and controlled sharing are central elements of the project. The platform developed enables efficient communication between sponsors and investigators, speeding up clinical trial protocol design and patient recruitment.
Statistical methods such as item response theory, factor analysis, regression models, and semiautomatic approaches such as lexical and semantic matching, have been also used for data harmonization. For example, Van den Berg et al. [78] confirmed the suitability of Item Response Theory (IRT) peculiarly in neuroticism and extraversion phenotypes harmonization by analyzing personality data from 160 671 individuals across 23 Genetics of Personality Consortium (GPC) cohorts (six twin cohorts) from Europe, USA, and Australia.
The fact that their approach was able to successfully identify a genetic variant associated with personality reveals an increase in the statistical power of the IRT in item-based behavioral measures harmonization. The proposed harmonization method was based on an unbiased personality score estimation process, which is known in IRT as "test-linking." This procedure was applied on each individual cohort and was conducted by IRT models which were appropriately fitted to the items. In addition, the IRT analysis revealed that the estimated neuroticism and extraversion scores were strongly independent of the corresponding inventory and heritable as well. Moreover, the unidimensionality of the items was assessed by plotting the test information curves for combinations of inventories as well as for each inventory separately whereas the variance of these items was assessed by a proposed Bayesian method for quantifying the noninvariance of the items across all cohorts.
Furthermore, Kern et al. [79] extracted harmonized child personality factors from two cohorts based on a five factor model that was originally developed for harmonizing child personality factors across the two studies. Regression models were developed in order to control for age and sex interactions across samples based on best-fitting model estimations. The prediction model was tested on each sample to assess the structure of the five factor model. Correlations were also computed between the predicted personality factors and similar factors from existing studies. The fact that the strong correlations between the generated harmonized variables and similar constructs from previous studies were strong confirms that the child personality factors were harmonized, thus enabling comparisons across both studies.
In [9] , the BiobankConnect software was tested across six biobanks under the EU-BioSHaRE HOP [1] , [48] on an integrated schema of 32 desired data elements across six biobanks from the BioSHaRE HOP which were marked as relevant or not for five out of six biobanks. Out of 41 184 matches, 420 were classified as relevant. An average precision of 0.75 was found at rank 1 and recall of 0.74, 0.82, and 0.88 at ranks 10, 20, and 50, respectively. According to the harmonization process, the potential of harmonizing a dataset was explored by means of manually matching the variables of interest to the target variables.
The Statistical Modeling of Aging and Risk (SMART) project [80] aims on studying the clinical phenotypes and risk factors of different neuropathologies, such as Mild Cognitive Impairment (MCI) and dementia as well as their progress and related combinations. It is comprised by 11 cohorts that combine longitudinal data on cognition and aging. The studies comprising the SMART project are well-established allowing for the application of various data mining strategies and statistical analysis procedures on the field of dementia and relative neuropathologies as well. The SMART dataset is already standardized due to the fact that all research centers had similar data templates in general. As a matter of fact, data harmonization was applied only for classifying individuals into two classes; impaired and nonimpaired, according to various neurophysiological test instruments. In order for the authors to deal with variations between scores, the latter were first predicted for various demographic factors (e.g., sex, age) using linear modeling. The predicted scores were then subtracted from the original ones and the normalized scores were used for classification. The ensuing results of the harmonization process were preliminary, representing a small portion of the SMART database. Table III highlights indicative case studies involving cohort harmonization in epidemiology which have further revealed important results related to successful harmonization outcomes with an additional high medical impact. These studies include tools that have been already presented in Table II (e.g., the BiobankConnect software, DataSHaPER, Opal), as well as, other similar tools. Moreover, the presented studies include valuable information about their open source data accessibility. For example, the DataSHaPER platform provides access to existing biobanks.
Several EU-funded studies on data harmonization were recently initiated by the European Commission under the PM04: Networking and optimizing the use of population and patient cohorts at EU level, HORIZON 2020 EU Research and Innovation programme. The HarmonicSS project [81] is an ongoing initiative that aims to harmonize regional, national, and international longitudinal cohorts of patients diagnosed with primary Sjögrens Syndrome by taking into consideration ethical, legal, and privacy issues to construct an integrative cloud-based cohort. On the latter, data mining, data governance, and visual analytics then will be developed as well as tools for clinical trial patient selection. Another EU initiative is the EUROlinkCAT (Establishing a linked European Cohort of Children with Congenital Anomalies) [82] which aims to enrich the existing EuroCHILD Cohort Network by bringing together pregnancy and child cohorts as well as biobanks to provide a shared data-management platform and harmonization strategies. The LifeBrain project [83] focuses on the integration, harmonization, and enrichment of major neuroimaging studies to obtain brain imaging, cognitive, and mental health measures of more than 6000 individuals in order to provide novel information regarding the brain deficits and diagnosis of brain disorders and therefore construct preventive and therapeutic strategies. The ESCAPE-NET (European Sudden Cardiac Arrest network: toward Prevention, Education and NEw Treatment) [84] is another ongoing project where European scientific teams have been gathered in order to design sudden cardiac arrest prevention and treatment strategies by combining existing European databases.
VI. DISCUSSION AND FUTURE DIRECTIONS
Data harmonization comprises a fundamental procedure prior to any data analysis across longitudinal cohorts and has been adopted by a variety of epidemiological studies, some of which are presented in the sequel. These studies mainly aim to investigate the potential of harmonizing large epidemiological datasets in order to generate a sustainable and robust dataset with induced variable heterogeneity that is capable of increasing the statistical power of the studies. Afterward, data pooling combined with straightforward data mining methods can be applied on the harmonized dataset to better comprehend the origins and the Data harmonization and integrative analysis of synthesized datasets have become increasingly important in the last decade. The invaluable sources of social, environmental, lifestyle factors, and genetic interactions and determinants, with reference to the disease onset, progression, and classification of different phenotypes, have given rise to data harmonization procedure. Moreover, this approach of data sharing facilitates the integration of the patient cohorts and the clinical picture and outcome during the disease management. Data harmonization can address the unmet needs of chronic diseases including the stratification of patients to distinct subgroups, the selection of new targets for therapy as well as the validation or identification of novel biomarkers.
Several key services and tools have been developed aiming to support data harmonization and coanalysis. Achieving harmonization of disparate studies as a rigorous scientific process improves the knowledge management and further the extraction of new scientific knowledge. When conducting data harmonization the definition of the research problem and the data quality, as well as the selection of the studies and the targeted variables constitute the basic steps. In addition, the processing of the final harmonized datasets and the estimation of their quality compose also key steps during the scientific procedure. In order to overcome the semantic heterogeneity obstacle among the different meanings of data elements, semantic technologies and matching techniques have been proposed and developed. Toward this, such approaches can help in data integration, when heterogeneity exists within different datasets and cohorts or when new relationships among data elements can be discovered. Besides that, ontologies and vocabularies can be used to organize knowledge regarding the power of linked data.
In addition, one of the major issues to consider when sharing and harmonizing data from different cohorts is the protection of ethical and legal aspects of the shared data. Toward this, several policies have been identified by either the clinical centers participating in data integration or expert legal offices that have been assigned the role of solving the legal constraints to share heterogeneous sources of information from different countries with different data protection laws and regulations. Concerning the protection laws across Europe when harmonizing different cohorts, the GDPR overhauls the EU DPD aiming to assure the availability and legality of the use of personal sensitive data. Specific rights of the data have been introduced with reference to the concept of privacy and the conditions of personal consent. Furthermore, the Framework for Responsible Sharing of Genomic and Health-Related Data has been developed, during the EU BioSHARE Project, and facilitates the responsible sharing of genomic and health-related patient data. In terms of the technological solutions for data protection, DataSHIELD initiative enables the coanalysis of data from heterogeneous sources, while addressing any ethics-related concern and data access approval.
In most of the described case studies, data harmonization is usually performed in a context-specific manner. More specifically, researchers define questions based on the type of epidemiology under examination. These research questions are combined with pairing rules in order to construct harmonized databases. In fact, the potential of harmonizing each individual dataset is explored by matching each study-related variable with those derived by a predefined (common) template based on the pairing rules. This process is a stepwise harmonization approach and is the most preferable way for harmonization, according to the existing literature. Moreover, the semantic interlinking mechanisms are easier to be implemented in this way since it is a study-related approach.
Noteworthy attempts have been recently accomplished toward establishing a semiautomatic data harmonization platform. An example of such an attempt is the DataSHaPER tool which is able to generate a complete harmonized dataset mainly for cancer epidemiology studies. In addition, the tools that were developed under the EU FP7 BioSHaRE project (i.e., the BiobankConnect software) constitute the fundamental basis for data harmonization and have been used in several studies which are described in this paper. The Opal and Mica software combined with the DataSchema variable template (from the DataSHaPER method) comprise the two main mechanisms used for data harmonization.
Statistical methods and IRT aspects comprise an alternative strategy for data harmonization. Toward this direction, regression models have been used for predicting measures (scores) in various epidemiological studies based on "best-fitting" models as well as to control for population (e.g., age, sex) differences among the cohorts under examination. Then, the predicted measures are compared with the original ones in order to evaluate the prediction model for data harmonization. Such approaches are less time-consuming than context-specific procedures but they are often complex.
Summarizing, harmonization is a challenging field with crucial methodological challenges yet to be met. These challenges mainly focus on barriers introduced by language differentiation and variables variation across the datasets, as well as by the definition and the context of the research questions. Harmonization is crucial prior to any meta-analysis in order to generate a sustainable and robust dataset with induced variable heterogeneity that will be capable of increasing the statistical power of the studies. However, in order to extend and better understand data harmonization, it is necessary to promote the description of existing harmonization procedures in epidemiology.
Harmonization is a rapidly evolving research field which has recently gained attention since it constitutes an emerging and promising approach for ensuring homogeneity across longitudinal epidemiological studies. Its importance lies on the innovation it offers for heterogeneous data integration. This evidence combined with the recent advances in machine learning, reinforcement learning, data mining strategies, and artificial intelligence can lead to the development of new data harmonization strategies yielding higher statistical power and harmonization quality, with minimum loss. This review can enhance relevant knowledge to such initiatives and thus provide a good impact in the scientific community.
